EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals

Sheng-Chieh Lin, Sing-Hua Tsou iD, Chien-Yin Kuo, Wei-Liang Chen iD, Kuan-Wen Wu iD, Chih-Li Lin iD, Chien-Ning Huang

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241210289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sheng-Chieh Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan. Hauptthemen laut MEDLINE: Apoptosis, Denosumab, Insulin-Secreting Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chung Shan Medical University Hospital, Taiwan National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is strongly associated with insulin sensitivity in type 2 diabetes (T2D), mainly because free fatty acids (FFAs) are released from excess fat tissue. Long-term exposure to high levels of FFAs and glucose leads to glucolipotoxicity, causing damage to pancreatic β-cells, thus accelerating the progression of T2D. Therefore, the prevention of β-cell dysfunction and apoptosis is essential to prevent the development of T2D. Unfortunately, there are currently no specific clinical strategies for protecting β-cells, highlighting the need for effective therapies or preventive approaches to improve the survival of β-cells in T2D. Interestingly, recent studies have shown that the monoclonal antibody denosumab (DMB), used in osteoporosis, displays a positive effect on blood glucose regulation in patients with T2D. DMB acts as an osteoprotegerin (OPG) by inhibiting the receptor activator of the NF-κB ligand (RANKL), preventing the maturation and function of osteoclasts. However, the exact mechanism by which the RANK/RANKL signal affects glucose homeostasis has not been fully explained. The present study used human 1.4 × 107 β-cells to simulate the T2D metabolic condition of high glucose and free fatty acids (FFAs), and it investigated the ability of DMB to protect β-cells from glucolipotoxicity. Our results show that DMB effectively attenuated the cell dysfunction and apoptosis caused by high glucose and FFAs in β-cells. This may be caused by blocking the RANK/RANKL pathway that reduced mammalian sterile 20-like kinase 1 (MST1) activation and indirectly increased pancreatic and duodenal homeobox 1 (PDX-1) expression. Furthermore, the increase in inflammatory cytokines and ROS caused by the RANK/RANKL signal also played an important role in glucolipotoxicity-induced cytotoxicity, and DMB can also protect β-cells by reducing the mechanisms mentioned above. These findings provide detailed molecular mechanisms for the future development of DMB as a potential protective agent of β-cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisDenosumabInsulin-Secreting CellsHumansDiabetes Mellitus, Type 2Fatty Acids, NonesterifiedGlucoseOsteoprotegerinRANK LigandReceptor Activator of Nuclear Factor-kappa B

Stichwörter der Autor:innen

RANK/RANKL pathwaydenosumabglucolipotoxicitypancreatic β-celltype 2 diabetes

Substanzen

DenosumabFatty Acids, NonesterifiedGlucoseOsteoprotegerinRANK LigandTNFRSF11A protein, humanReceptor Activator of Nuclear Factor-kappa BTNFSF11 protein, human

Autor:innen und Institutionen

  • Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
  • Department of Orthopaedics, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • Department of Surgery, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • Department of Internal Medicine, Division of Gastroenterology and Hepatology, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
  • Department of Orthopaedic Surgery, National Taiwan University Hospital, Taipei 100, Taiwan.

ORCID-Profile: Sing-Hua Tsou, Wei-Liang Chen, Kuan-Wen Wu, Chih-Li Lin

Förderung

  • Chung Shan Medical University Hospital
  • Taiwan National Science and Technology Council

Zitieren

APA

Lin, S. C., Tsou, S. H., Kuo, C. Y., Chen, W. L., Wu, K. W., Lin, C. L., & Huang, C. N. (2023). Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210289

Vancouver

Lin SC, Tsou SH, Kuo CY, Chen WL, Wu KW, Lin CL, et al. Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210289

BibTeX
@article{Lin2023,
  author = {Lin, Sheng-Chieh and Tsou, Sing-Hua and Kuo, Chien-Yin and Chen, Wei-Liang and Wu, Kuan-Wen and Lin, Chih-Li and Huang, Chien-Ning},
  title = {Denosumab Attenuates Glucolipotoxicity-Induced β-Cell Dysfunction and Apoptosis by Attenuating RANK/RANKL Signals},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241210289}
}
Kostenlos starten →